Clinical Trial Update: Comparision Between Activated Partial Thromboplastin Time Versus Anti-Xa Activity in Heparin Monitoring [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial compares activated partial thromboplastin time (APTT) versus anti-Xa activity for monitoring heparin therapy. The sponsor lists myocard…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bleeding
• Myocardial Infarction
• Stroke
• Venous Thromboembolism

Drugs mentioned

• Unfractionated Heparin (unfractionated heparin)

Snippet

Sponsor: Wuhan Asia Heart Hospital | Conditions: Myocardial Infarction, Venous Thromboembolism | Phase 4 | Status: UNKNOWN